- Health & Pharmaceuticals›
- Pharmaceutical Products & Market›
Median length of orphan and non-orphan drugs in phase III trial 2015
Industry-specific and extensively researched technical data (partially from exclusive partnerships).
A paid subscription is required for full access.
Median length of orphan and non-orphan drugs in phase III trial 2015
Median phase III trial length for orphan and non-orphan drugs as of 2015 (in years)
This statistic displays the median length of time that orphan and non-orphan products are in phase III trial, as of 2015. Orphan drugs were in phase III trials for a median of 2.89 years. Orphan drugs are used to target rare diseases or disorders, which in the United States is defined as less than 200,000 patients. The development of orphan drugs are currently incentivized in the United States through the Orphan Drug Act of 1983.
Median phase III trial length for orphan and non-orphan drugs as of 2015 (in years)
| Median length of time in years | |
|---|---|
| - | - |
| - | - |
| - | - |
| Median length of time in years | |
|---|---|
| - | - |
| - | - |
| - | - |
You need a Premium Account for unlimited access.
Full access to 1m statistics
Incl. source references
Available to download in PNG, PDF, XLS format
You need a Premium Account for unlimited access.
Full access to 1m statistics
Incl. source references
Available to download in PNG, PDF, XLS format
© Statista 2019
About this statistic
Show source
Please be patient - this may take a moment
Description
Source
More information
- Show sources information
- Show publisher information
- Release date
- October 2015
- Region
- Worldwide
- Survey time period
- 2015
Source
- Show sources information
- Show publisher information
- Release date
- October 2015
More information
- Region
- Worldwide
- Survey time period
- 2015
Other statistics on the topic
+Pharmaceutical Products & Market
Leading 18 European pharmaceutical companies by retail sales 2015
+Pharmaceutical Products & Market
Turnover of leading European pharmaceutical markets 2017
Pharmaceutical Products & Market
Self-medication market sales in Europe in 2017, by country
+Pharmaceutical Products & Market
Turnover of pharmaceutical markets in Central and Eastern Europe 2017
You only have access to basic statistics.
This statistic is not included in your account!
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$59 / Month *
Corporate solution including all features.
Prices do not include sales tax.
Statista has been my savior on several occasions. The site is easy to maneuver and the data is in a format that can go right into a report or presentation.Marlene Greenfield
Vice President, Hearst Magazines
- Industry overview
- Turnover of leading pharmaceutical markets in Europe in 2017 (in million euros)Turnover of leading European pharmaceutical markets 2017
- Turnover of pharmaceutical markets in Central and Eastern Europe in 2017 (in million euros)Turnover of pharmaceutical markets in Central and Eastern Europe 2017
- Number of drugstores in the Netherlands in 2018, by typeNumber of drugstores in the Netherlands 2018, by type
- Annual revenue of pharmaceutical care within the basic health insurance package from 2008 to 2018 (in million euros)Pharmaceutical revenue within basic health insurance in the Netherlands 2008-2018
- Most frequently used medicines among youth in the Netherlands in 2015* Most frequently used medicines among youth in the Netherlands 2015
- Leading medicines with the highest usage in the Netherlands in 2018 (in millions)Leading medicines with the highest usage in the Netherlands 2018
- Leading medicines with the highest expenditure in the Netherlands in 2018 (in million euros)*Medicines with the highest expenditure in the Netherlands 2018
- Leading prescribed medicines in the Netherlands in 2018, by total expenditure (in million euros)*Prescribed medicines in the Netherlands in 2018, by total expenditure
- Dispensed medicines
- Number of dispensed diabetes medicines and goods in the Netherlands from 2013 to 2017*Dispensed diabetes medicines and goods in the Netherlands 2013-2017
- Number of dispensed asthma/COPD medicines in the Netherlands from 2013 to 2017*Dispensed asthma/COPD medicines in the Netherlands 2013-2017
- Number of dispensed analgesics in the Netherlands from 2013 to 2017*Dispensed analgesics in the Netherlands 2013-2017
- Number of dispensed antiepileptic medicines in the Netherlands from 2013 to 2017*Dispensed antiepileptic medicines in the Netherlands 2013-2017
- Number of dispensed antidepressants in the Netherlands from 2013 to 2017*Dispensed antidepressants in the Netherlands 2013-2017
- Total usage of dispensed diabetes medicines and goods in the Netherlands from 2013 to 2017*Usage of dispensed diabetes medicines and goods in the Netherlands 2013-2017
- Total usage of dispensed asthma/COPD medicines in the Netherlands from 2013 to 2017 (in 1,000s)Usage of dispensed asthma/COPD medicines in the Netherlands 2013-2017
- Total number of users of dispensed antiepileptic medicines in the Netherlands from 2013 to 2017*Usage of dispensed antiepileptic medicines in the Netherlands 2013-2017
- Self-care medication
- Sales in the self-medication market in selected European countries in 2017 (in million euro)Self-medication market sales in Europe in 2017, by country
- Annual revenue of self-care medicines in the Netherlands in 2018, by product segment (in million euros)*Revenue of self-care medicines in the Netherlands 2018, by product segment
- Sales revenue of self-care medicines in the Netherlands in 2018, by purchase channel (in million euros)Sales revenue of self-care medicines in the Netherlands 2018, by purchase channel
- Percentage change on previous year of the revenue in self-care medicines in the Netherlands in 2018, by product segmentRevenue change in self-care medicines in the Netherlands 2018, by product segment
- Distribution of self-care medicines sales in the Netherlands in 2018, by purchase channel*Distribution self-care medicines sales in the Netherlands 2018, by purchase channel
- Sales revenue of self-care medicines in supermarkets in the Netherlands in 2018, by product segment (in million euros)Revenue of self-care medicines in supermarkets in the Netherlands 2018, by segment
- Pharmacies
- Leading 18 European pharmaceutical companies by retail sales in 2015 (in billion U.S. dollars)Leading 18 European pharmaceutical companies by retail sales 2015
- Number of pharmacies in the Netherlands from 2012 to 2018*Number of pharmacies in the Netherlands 2012-2018
- Number of public pharmacies in the Netherlands from 2015 to 2018, by typeNumber of public pharmacies in the Netherlands 2015-2018, by type
- Average medicine costs and tariff revenues per pharmacy in the Netherlands from 2011 to 2018 (in 1,000 euros)Average medicine costs and tariff revenues per pharmacy in the Netherlands 2011-2018
- Average pharmacy costs per person under the Dutch Health Insurance Act (Zvw) from 2009 to 2017 (in euros)Pharmacy costs per person under the Dutch Health Insurance Act (Zvw) 2009-2017
- Average pharmacy costs per person under the Dutch Health Insurance Act (Zvw) from 2009 to 2017, by gender (in euros)Pharmacy costs per person under Dutch Health Insurance Act (Zvw) 2009-2017, by gender
- Required number of patients for phase III trials of orphan and non-orphan drugs 2015
- Number of cumulative orphan designations accepted in the U.S. 2003-2018
- Average FDA approved orphan drug sales U.S. 5 years after launch 2014
- Top new orphan molecular entities by U.S. sales in 2019
- Leading orphan designations in the EU by indication 2015
- Median length of time for orphan and non-orphan drugs for FDA approval 2015
- Orphan drug sales worldwide excluding oncology by therapy category 2024
- Orphan vs. non-orphan pipeline sales forecast worldwide 2019-2024
- Worldwide share of orphan drug sales by therapy category without oncology 2024
- Orphan vs. non-orphan drugs median cost per patient per year 2014-2018
- Worldwide Rx drug sales excluding generics and orphan drugs 2002-2024
- Pricing of orphan drugs across three countries on annual basis 2016
- Utilization of orphan drugs in the U.S. by usage type 2014
- Utilization of orphan drugs in the U.S. from 2012 to 2014, by usage type
- Cumulative price change of orphan drugs in the U.S. 2012-2014
- Number of orphan drugs used in Norway 2016-2018
- U.S. orphan drugs with patents and orphan drug exclusivity as of 2018
- Impact of clinical trials on the daily lives of participants globally 2017
- U.S. orphan drugs with patents and orphan drug exclusivity as of 2018, by duration
- Ad spending for Amgen's top product Enbrel U.S. 2014-2015
Statista offers dossiers and reports on over 170 industries. With Statista you are always able to make informed decisions and boost your work efficiency.
- Social Media
- E-Commerce
- Online Video & Entertainment
- Advertising & Marketing
- Alcoholic Beverages
- Cleaning Products
- Cosmetics & Personal Care
- Food & Nutrition
- Health & Hygiene
- International Trade
- Shopping Behavior
- Sports & Leisure
- Business Travel
- Leisure Travel
- Accomodation
- Restaurants
- Demographics
- Economy
- Education & Science
- Politics & Government
- Aviation
- Rail Transport
- Vehicles & Road Traffic
- Water Transport
You can only download this statistic as a Premium user.
You can only download this statistic as a Premium user.
You can only download this statistic as a Premium user.
As a Premium user you get access to the detailed source references and background information about this statistic.
As a Premium user you get access to background information and details about the release of this statistic.
As soon as this statistic is updated, you will immediately be notified via e-mail.
...and make my research life easier.
You need at least a Premium Account to use this feature.
This feature is limited to our corporate solutions.
Please contact us to get started with full access to dossiers, forecasts, studies and international data.
We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.